Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Mumford

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Annals of Surgery|March 8, 2022
Liver Transplantation Outcomes From Controlled Circulatory Death Donors: SCS vs in situ NRP vs ex situ NMPRohit Gaurav, Andrew J Butler, Vasilis Kosmoliaptsis, et al.
Frontiers in Nephrology|September 7, 2023
Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival-it is time for rigorous patient blood managementSevda Hassan, Lisa Mumford, Susan Robinson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 15, 2018
For the many: permitting deceased donor kidney transplantation across low-titre blood group antibodies can reduce wait times for blood group B recipients, and improve the overall number of 000MM transplants - a multicentre observational cohort studyMiriam Manook, Lisa Mumford, Alec Nicholas R Barnett, et al.
Transplantation|February 2, 2023
Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort StudyChris J Callaghan, Rebecca M K Curtis, Lisa Mumford, et al.
Transplantation|January 4, 2022
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant RecipientsChris J Callaghan, Lisa Mumford, Rebecca M K Curtis, et al.
Transplantation Direct|July 15, 2017
The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 TransplantsLaura Pankhurst, Alex Hudson, Lisa Mumford, et al.
Clinical Transplantation|December 28, 2020
The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first waveGillian Hardman, Ruth Sutcliffe, Rachel Hogg, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Clinical Transplantation|February 20, 2021
Heart transplantation in the UK during the first wave of the SARS-CoV-2 pandemicGillian Hardman, Ruth Sutcliffe, Rachel Hogg, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Surgery|March 8, 2022
Liver Transplantation Outcomes From Controlled Circulatory Death Donors: SCS vs in situ NRP vs ex situ NMPRohit Gaurav, Andrew J Butler, Vasilis Kosmoliaptsis, et al.
Frontiers in Nephrology|September 7, 2023
Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival-it is time for rigorous patient blood managementSevda Hassan, Lisa Mumford, Susan Robinson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 15, 2018
For the many: permitting deceased donor kidney transplantation across low-titre blood group antibodies can reduce wait times for blood group B recipients, and improve the overall number of 000MM transplants - a multicentre observational cohort studyMiriam Manook, Lisa Mumford, Alec Nicholas R Barnett, et al.
Transplantation|February 2, 2023
Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort StudyChris J Callaghan, Rebecca M K Curtis, Lisa Mumford, et al.
Transplantation|January 4, 2022
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant RecipientsChris J Callaghan, Lisa Mumford, Rebecca M K Curtis, et al.
Transplantation Direct|July 15, 2017
The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 TransplantsLaura Pankhurst, Alex Hudson, Lisa Mumford, et al.
Clinical Transplantation|December 28, 2020
The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first waveGillian Hardman, Ruth Sutcliffe, Rachel Hogg, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Clinical Transplantation|February 20, 2021
Heart transplantation in the UK during the first wave of the SARS-CoV-2 pandemicGillian Hardman, Ruth Sutcliffe, Rachel Hogg, et al.
Pageof 3